INTRODUCTION AND OBJECTIVES: 1-3% of all GP consultation in the UK are related to Urinary Tract Infections (UTI) [1] , with the majority managed in primary care. Nevertheless, recurrent [r] UTIs requires urological input. The standard management includes lifestyle and behavior modifications, non-microbial measures and antibacterial prophylactics.
This study aimed to assess the benefit of Intra-Vesical Gentamicin (IVG) in reducing rUTI, impact on pain scores and if its usage increases antibiotic resistance in patients who failed conventional treatments.
METHODS: A treatment protocol was developed and approved by the local Clinical Effectiveness Committee. Inclusion criteria were patients who failed all conventional treatments with clinical data available twelve months before and a variable period after initiating prophylactic IVG installations. These patients had at least 6 symptomatic UTIs (þve MSU and requiring treatment with Antibiotics (Abx)) or at least one admission with urosepsis needing Intra-Venous (IV) Abx.
All patients consented to this off-license use of IVG. A single nightly installation of 80 mg Gentamicin diluted in 50 ml of 0.9% normal saline was instigated. Serum Gentamicin levels were checked seven days post-treatment. If levels were > 1.0 mg/L treatment had to be discontinued (all patient levels were < 1.0 mg/L). Daily instillations were reduced in frequency over subsequent months dictated by response.
RESULTS: Eleven patients were included (ten females, one male) with an average age of 45 (70-22), average BMI: 23.6 (29-17) and average treatment period: 7 months (2-18). All patients were independent in administration. Overall 10 out of 11 (91%) had an improvement in their pelvic pain & rate of rUTI. Comparing pre and post IVG results, there was improvement in pain scores 9.8/10 to 5.1/10 and number of symptomatic UTIs reduced from 8.3 to 1.8. There were fewer admissions for intravenous ABx (mean 1.45 to 0.36) and fewer multidrug resistance organisms after IVG (mean 7.38 vs. 1).
Interestingly, out of the 97 positive MSUs pre-IVG three MSUs grow Gentamicin resistance microorganisms and the post-IVG MSUs none of the microorganisms showed resistance to Gentamicin.
CONCLUSIONS: The initial results have shown that IVG improves QoL, can be used safely and without increasing multidrugresistant microorganisms in treating intractable UTI that failed conventional treatment. Further follow up is required as a more prolonged period post-treatment is needed to assess effectiveness. METHODS: This prospective randomized single blinded study compared electro-acupuncture (EA) to minimal acupuncture (MA) after 6 weekly sessions (end of treatment, EOT) and at 12 weeks, after 6 weeks of no treatment, in women with > 6 months of symptoms. One urologist double boarded in medical acupuncture performed the acupuncture and exam. The Brief Pain Inventory-Short Form was used to assess pain (worst pain, average pain, and pain severity) and quality of life (pain interference), with the primary outcome being worst pain. Pelvic exam was performed to assess pelvic floor muscle tenderness. Linear mixed-effects models were used to estimate mean and standard error of pain scores at baseline, EOT, and at 12 weeks.
RESULTS: 21 patients were randomized to EA (n[11) or MA (n[10). There were no reported adverse events. Both groups showed significant improvement in worst pain at the EOT with a decrease of -2.91AE0.59 (p[0.007) and -2.09AE0.68 (p<0.001) for EA and MA respectively with no difference between groups (p[0.37). Results were similar at 12 weeks. Average pain and pain severity also showed improvement for both groups at the EOT with no difference between groups (p>0.05), but only the EA group maintained improvement at 12 weeks. The EA group had greater improvement in pain interference at the EOT, -3.28AE0.51 versus -1. 67AE0.58 (p[ 0.049) . The within group change was still significant for the EA group at 12 weeks p[0.002) , between group difference was not maintained (p[0.13). Only the EA group showed significant decrease in levator ani tenderness (p<0.05) at the EOT.
CONCLUSIONS: EA showed greater improvement in pain interference, pelvic floor muscle tenderness, with continuing effects on pain scores at 12 weeks compared to MA. This study demonstrates that patients tolerate and improve with weekly acupuncture treatment sessions and that EA specifically may improve quality of life for women with PBS. Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e695
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